These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


490 related items for PubMed ID: 3948063

  • 1. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D, Eydt JN.
    CMAJ; 1986 Mar 01; 134(5):495-501. PubMed ID: 3948063
    [Abstract] [Full Text] [Related]

  • 2. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF, Mercer CJ, Roche AH, Lowe JB.
    N Z Med J; 1981 Jan 28; 93(676):31-5. PubMed ID: 6940024
    [Abstract] [Full Text] [Related]

  • 3. Control of refractory cardiac arrhythmias with amiodarone.
    Leak D, Eydt JN.
    Arch Intern Med; 1979 Apr 28; 139(4):425-8. PubMed ID: 434996
    [Abstract] [Full Text] [Related]

  • 4. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
    Kerin NZ, Rubenfire M, Blevins RD, Frumin H, Faitel K, Jarandilla R, Aragon E, Marinescu G, Luarca R.
    Clin Cardiol; 1988 Mar 28; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ, Prystowsky EN, Jackman WM, Naccarelli GV, Warfel KA, Rinkenberger RL, Zipes DP.
    N Engl J Med; 1981 Sep 03; 305(10):539-45. PubMed ID: 6789201
    [Abstract] [Full Text] [Related]

  • 6. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE.
    Clin Pharm; 1983 Sep 03; 2(4):330-40. PubMed ID: 6349912
    [Abstract] [Full Text] [Related]

  • 7. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A.
    G Ital Cardiol; 1999 May 03; 29(5):514-23. PubMed ID: 10367218
    [Abstract] [Full Text] [Related]

  • 8. [Amiodarone therapy in childhood: efficacy and side effects].
    Vignati G, Danzi GB, Austoni P, Fancini P, Mascarello M, Figini A.
    G Ital Cardiol; 1985 Aug 03; 15(8):786-94. PubMed ID: 2935440
    [Abstract] [Full Text] [Related]

  • 9. Short- and intermediate-term efficacy of amiodarone in infants and children with cardiac arrhythmia.
    Celiker A, Koçak G, Lenk MK, Alehan D, Ozme S.
    Turk J Pediatr; 1997 Aug 03; 39(2):219-25. PubMed ID: 9223920
    [Abstract] [Full Text] [Related]

  • 10. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J, Hidden F, Naditch L, Coutte R, Himbert C, Frank R.
    Ann Cardiol Angeiol (Paris); 1996 Jan 03; 45(1):18-23. PubMed ID: 8815771
    [Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of amiodarone hydrochloride as an anti-arrhythmia agent].
    Malpartida F, Triola M, Huguet R, Sala J, Noguera J, Cordeiro B.
    Rev Med Univ Navarra; 1975 Jan 03; 19(1):143-9. PubMed ID: 1234780
    [Abstract] [Full Text] [Related]

  • 12. Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations.
    Installe E, Schoevaerdts JC, Gadisseux P, Charles S, Tremouroux J.
    J Thorac Cardiovasc Surg; 1981 Feb 03; 81(2):302-8. PubMed ID: 7453241
    [Abstract] [Full Text] [Related]

  • 13. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R, Agha A, Giorgi C, Shenasa M, Nadeau R.
    Can J Cardiol; 1989 Mar 03; 5(2):98-104. PubMed ID: 2706579
    [Abstract] [Full Text] [Related]

  • 14. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P.
    Circulation; 2004 Jul 13; 110(2):112-6. PubMed ID: 15238454
    [Abstract] [Full Text] [Related]

  • 15. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A, Massacci C, Curzi G, Pigini G, Costantini C, Bilancini A, Blandini A.
    G Ital Cardiol; 1986 May 13; 16(5):417-26. PubMed ID: 3732727
    [Abstract] [Full Text] [Related]

  • 16. Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome.
    Shahar E, Barzilay Z, Frand M, Feigl A.
    Pediatrics; 1983 Dec 13; 72(6):813-6. PubMed ID: 6646922
    [Abstract] [Full Text] [Related]

  • 17. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov 13; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 18. Amiodarone in the treatment of patients with refractory symptomatic ventricular and supraventricular arrhythmias. A long-term follow-up study.
    Lloyd EA, Mabin TA.
    S Afr Med J; 1983 May 14; 63(20):759-63. PubMed ID: 6342169
    [Abstract] [Full Text] [Related]

  • 19. [Electrocardiographic effects and antiarrhythmic action of 1200 mg of oral amiodarone per day].
    Tonet JL, Lechat P, Frank R, Lascault G, Fontaine G, Facquet J, Cohen A, Grosgogeat Y.
    Ann Cardiol Angeiol (Paris); 1984 May 14; 33(5):309-15. PubMed ID: 6476769
    [Abstract] [Full Text] [Related]

  • 20. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
    Manning AS, Bruyninckx C, Ramboux J, Chatelain P.
    J Cardiovasc Pharmacol; 1995 Sep 14; 26(3):453-61. PubMed ID: 8583788
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.